Critical Reviews in Oncology/Hematology : Impact Factor & More
eISSN: 1879-0461pISSN: 1040-8428
Share this on:
Key Metrics
CiteScore 
9.7
Impact Factor
5 - 10
SJR
Q1Oncology
SNIP
1.75
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Critical Reviews in Oncology/Hematology
Critical Reviews in Oncology/Hematology Journal Specifications
| Overview | |
| Publisher | ELSEVIER SCIENCE INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1989 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Critical Reviews in Oncology/Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Critical Reviews in Oncology/Hematology
Inflammatory breast cancer: Improving research and care through the integration of preclinical evidence and technological advances.
- 1 Nov 2026
- Critical reviews in oncology/hematology
Germline variants and impact on lung cancer outcomes following chemotherapy: A systematic review.
- 1 Oct 2026
- Critical reviews in oncology/hematology
Brain tumor susceptibility: From genetic predisposition syndromes to extended characterization of genomic determinants.
- 1 Sep 2026
- Critical reviews in oncology/hematology
Hybrid membrane nanosystems for cancer immunotherapy: Biomimetic design, immune activation, and translational potential.
- 1 Sep 2026
- Critical reviews in oncology/hematology
Ferroptosis in glioblastoma: Molecular determinants, immune crosstalk, and therapeutic opportunities.
- 1 Sep 2026
- Critical reviews in oncology/hematology
Detection, occurrence, development, diagnosis and treatment of vaginal microbiome in gynecological cancers.
- 8 Aug 2026
- Critical reviews in oncology/hematology
Inflammatory breast cancer: Improving research and care through the integration of preclinical evidence and technological advances.
- 1 Nov 2026
- Critical reviews in oncology/hematology
Germline variants and impact on lung cancer outcomes following chemotherapy: A systematic review.
- 1 Oct 2026
- Critical reviews in oncology/hematology
Brain tumor susceptibility: From genetic predisposition syndromes to extended characterization of genomic determinants.
- 1 Sep 2026
- Critical reviews in oncology/hematology
Hybrid membrane nanosystems for cancer immunotherapy: Biomimetic design, immune activation, and translational potential.
- 1 Sep 2026
- Critical reviews in oncology/hematology
Ferroptosis in glioblastoma: Molecular determinants, immune crosstalk, and therapeutic opportunities.
- 1 Sep 2026
- Critical reviews in oncology/hematology
Detection, occurrence, development, diagnosis and treatment of vaginal microbiome in gynecological cancers.
- 8 Aug 2026
- Critical reviews in oncology/hematology
FAQs on Critical Reviews in Oncology/Hematology
How long has Critical Reviews in Oncology/Hematology been actively publishing? 
What is the publishing frequency of Critical Reviews in Oncology/Hematology?
How many articles did Critical Reviews in Oncology/Hematology publish last year?
What is the eISSN & pISSN for Critical Reviews in Oncology/Hematology?
What is Citescore for Critical Reviews in Oncology/Hematology?
What is SNIP score for Critical Reviews in Oncology/Hematology?
What is the SJR for Critical Reviews in Oncology/Hematology?
Who is the publisher of Critical Reviews in Oncology/Hematology?
